Fiduxosin

98%

  • Product Code: 108297
  CAS:    208993-54-8
Molecular Weight: 555.65 g./mol Molecular Formula: C₃₀H₂₉N₅O₄S
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: Fiduxosin is primarily investigated for its potential therapeutic applications in the treatment of benign prostatic hyperplasia (BPH). It functions as an alpha-1 adrenergic receptor antagonist, which helps relax the smooth muscles in the prostate and bladder neck, thereby improving urine flow and reducing symptoms associated with BPH, such as difficulty in urination, frequent urination, and incomplete bladder emptying. Its selective action on alpha-1 receptors aims to minimize side effects commonly seen with non-selective alpha blockers, making it a promising candidate for managing this condition. Research continues to explore its efficacy and safety profile in clinical settings.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days Ft6,769,695.28
+
-
Fiduxosin
Fiduxosin is primarily investigated for its potential therapeutic applications in the treatment of benign prostatic hyperplasia (BPH). It functions as an alpha-1 adrenergic receptor antagonist, which helps relax the smooth muscles in the prostate and bladder neck, thereby improving urine flow and reducing symptoms associated with BPH, such as difficulty in urination, frequent urination, and incomplete bladder emptying. Its selective action on alpha-1 receptors aims to minimize side effects commonly seen with non-selective alpha blockers, making it a promising candidate for managing this condition. Research continues to explore its efficacy and safety profile in clinical settings.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: Ft0.00
Ft0.00 Total :